XbiotechXBIT
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 46 institutions reported holding Xbiotech Inc. (XBIT) in their 13F filings, unchanged from Q1 2024. 12 opened new positions and 12 sold out. The largest holders were BlackRock Inc. ($5.8M), Vanguard Group Inc. ($5.3M) and Geode Capital Management, LLC ($2.2M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Xbiotech Inc.
- CUSIP
- 98400H102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $2.1M |
| Exits | 12 | $3.2M |
All 13F filers, Q1 2024 → Q2 2024: 1,921,029 shares bought and 1,161,081 shares sold, net +759,948 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| BlackRock Inc. | 0.00% | Add +269.9% | 1,134,146 | $5.8M |
| Vanguard Group Inc. | 0.00% | Add +15.8% | 1,036,969 | $5.3M |
| Geode Capital Management, LLC | 0.00% | Add +120.4% | 430,205 | $2.2M |
| Millennium Management | 0.00% | Reduce -61.0% | 361,661 | $1.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 248,270 | $1.3M |
| State Street Corp. | 0.00% | Add +258.9% | 202,843 | $1.0M |
| Bridgeway Capital Management, LLC | 0.02% | Add +3.3% | 154,178 | $792K |
| Morgan Stanley | 0.00% | Reduce -13.6% | 100,551 | $517K |
| Bank of New York Mellon Corp | 0.00% | Add +102.9% | 98,314 | $505K |
| Northern Trust Corp. | 0.00% | Add +4.0% | 78,407 | $403K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +0.4% | 77,723 | $399K |
| American Century Companies Inc. | 0.00% | New | 76,460 | $393K |
| Dimensional Fund Advisors LP | 0.00% | No change | 72,475 | $371K |
| Empowered Funds, LLC | 0.01% | Add +7.6% | 69,137 | $355K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +416.7% | 54,139 | $278K |
| National Bank of Canada | 0.00% | No change | 33,000 | $182K |
| Nuveen Asset Management, LLC | 0.00% | New | 24,879 | $128K |
| T. Rowe Price Associates Inc. | 0.00% | Add +34.2% | 23,625 | $122K |
| New York State Common Retirement Fund | 0.00% | New | 21,700 | $112K |
| FMR LLC | 0.00% | Add +8.0% | 21,572 | $111K |
| Rhumbline Advisers | 0.00% | Add +2568.5% | 20,094 | $103K |
| Alpine Global Management, LLC | 0.02% | New | 17,809 | $92K |
| BNP Paribas Financial Markets | 0.00% | Add +12.2% | 14,053 | $72K |
| Thomasville National Bank | 0.01% | No change | 13,350 | $69K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -78.8% | 13,166 | $68K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -80.9% | 12,917 | $66K |
| Synovus Financial Corp. | 0.00% | No change | 11,796 | $61K |
| UBS Group AG | 0.00% | Add +44.6% | 10,618 | $55K |
| Man Group plc | 0.00% | New | 10,611 | $55K |
| Marshall Wace, LLP | 0.00% | Reduce -80.7% | 10,573 | $54K |
| Bank of America Corp. | 0.00% | Add +19.3% | 10,363 | $53K |
| Corebridge Financial, Inc. | 0.00% | — | 9,955 | $51K |
| Wells Fargo & Company | 0.00% | Add +5144.5% | 8,129 | $42K |
| JPMorgan Chase & Co. | 0.00% | Add +20752.6% | 7,924 | $41K |
| Barclays PLC | 0.00% | New | 7,582 | $39K |
| Citadel Advisors | 0.00% | Reduce -30.6% | 4,890 | $25K |
| Citigroup Inc. | 0.00% | Reduce -88.7% | 4,154 | $21K |
| Royal Bank of Canada | 0.00% | Add +1867.7% | 1,948 | $11K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,813 | $9K |
| Legal & General Group Plc | 0.00% | New | 1,598 | $8K |
| California State Teachers Retirement System | 0.00% | New | 1,341 | $7K |
| McIlrath & Eck, LLC | 0.00% | No change | 753 | $4K |
| Amalgamated Bank | 0.00% | New | 640 | $3K |
| US Bancorp \de | 0.00% | New | 100 | $514 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -97.0% | 33 | $170 |
| Simplex Trading, LLC | 0.00% | Reduce -45.6% | 124 | $0 |
"% of holder's portfolio" is XBIT's weight in each manager's 13F, not the share of Xbiotech Inc. the manager owns.